Search

Russell F Somma

from Sparta, NJ
Age ~72
Get Report
Also known as:
Russell Francis Somma, Russell S Somma, Somma Russell, Russel F Somma, Russell F Summa
Phone and address:
5 Shady Ln, Sparta, NJ 07871
(973) 729-0960
Related to:
Linda G Clamp, 57Dawn Nicita, 53Leonard Levy, 87Maria C Levy, 72Leslie Toledo, 64Leslie K Efthimiades, 61
Connected to:
Alexander J Somma, 32Christopher Somma, 30Dawn R Somma, 51Diana Somma, 36Janine M Somma, 60Joyce M Somma, 60Kayla M Somma, 36Mitchell M Somma, 52Ronald A Somma, 67Jeffrey J Sommar, 50

Russell Somma Phones & Addresses

  • 5 Shady Ln, Sparta, NJ 07871 (973) 729-0960 (973) 729-4341
  • Vienna, VA
  • New Providence, NJ
  • New Providnce, NJ

Publications

Us Patents

Benzonatate Compositions And Methods Of Use

View page
US Patent:
8357398, Jan 22, 2013
Filed:
Oct 20, 2010
Appl. No.:
12/925353
Inventors:
William Wayne Howard - Morristown NJ, US
Russell Francis Somma - Sparta NJ, US
Doreen Marie Frank - Lebenon NJ, US
Assignee:
Alitair Pharmaceuticals Inc. - Morris Plains NJ
International Classification:
A61K 9/14
A61K 9/20
A61K 9/54
A61K 31/075
A61K 31/245
B01J 45/00
US Classification:
424483, 424465, 424501, 514538, 514544, 514716, 514717, 514718, 521 30
Abstract:
Oral dosage forms of benzonatate useful for anti-tussive and anti-tussive/combination applications.

Immediate Release Compositions And Methods For Delivering Drug Formulations Using Weak Acid Ion Exchange Resins In Abnormally High Ph Environments

View page
US Patent:
8617602, Dec 31, 2013
Filed:
Apr 23, 2012
Appl. No.:
13/506512
Inventors:
William Wayne Howard - Morristown NJ, US
Russell Francis Somma - Sparta NJ, US
Sajeev Chandran - Pune IN, US
Pravin Megharji Bhutada - Pune IN, US
Ashish Ashokkao Deshmukh - Pune IN, US
Hemant Hanumant Bhalerao - Pune IN, US
International Classification:
A61K 9/24
US Classification:
424472, 424400, 424465, 424452, 424483
Abstract:
Multi-layer solid oral dosage immediate release and extended release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments.

Pharmaceutical Composition Which Reduces Or Eliminates Drug Abuse Potential

View page
US Patent:
20020187192, Dec 12, 2002
Filed:
Aug 30, 2001
Appl. No.:
09/942808
Inventors:
Yatindra Joshi - Princeton NJ, US
Russell Somma - Sparta NJ, US
International Classification:
A61K009/14
A61K031/137
US Classification:
424/484000, 424/486000, 424/488000, 514/649000
Abstract:
A pharmaceutical composition which reduces or eliminates the drug abuse potential of central nervous system stimulant comprising: (a) a drug selected from the group consisting of methylphenidate, amphetamine, methamphetamine, and combinations thereof; and (b) a gel forming polymer wherein the gel forming polymer is a polymer that forms a gel when contacted with moisture or placed in an aqueous solution. The present invention is based on the discovery that a central nervous system stimulant such as methylphenidate in combination with a gel forming polymer reduces or eliminates drug abuse potential by swelling in the presence of moisture, and thus, preventing nasal absorption and injectability of the drug.

Pharmaceutical Composition Which Produces Irritation

View page
US Patent:
20030049272, Mar 13, 2003
Filed:
Aug 30, 2001
Appl. No.:
09/942809
Inventors:
Yatindra Joshi - Princeton NJ, US
Russell Somma - Sparta NJ, US
International Classification:
A61K038/00
A61K031/137
A61K031/401
A61K031/366
A61K035/78
A61K031/195
A61K033/38
A61K031/19
US Classification:
424/195180, 514/002000, 514/649000, 424/725100, 424/760000, 424/619000, 424/722000, 514/162000, 514/557000, 514/569000, 514/423000, 514/643000, 514/567000, 514/575000, 514/460000
Abstract:
A pharmaceutical composition which reduces or eliminates the drug abuse potential of central nervous system stimulant comprising: (a) a central nervous system stimulant selected from the group consisting of methylphenidate, amphetamine, methamphetamine, and combinations thereof; and (b) a mucous membrane irritant selected from the group consisting of organic and inorganic acid, salt, ketone, nitrite, sulfide, bisulfate, persulfate, glycerophosphate, hypophosphate, borate, titanate, amino acid, peptide, and combinations thereof, wherein the mucous membrane irritant produces irritation when contacted with the skin or mucous membrane. The present invention is based on the discovery that a central nervous system stimulant, such as methylphenidate, in combination with a mucous membrane irritant, such as citric acid, reduces or eliminates potential drug abuse by producing “irritation” when contacted with the dermis layer of skin or mucous membrane, and thus, prevents nasal absorption and/or injectability of the drug.

Pharmaceutical Composition Which Produces Irritation

View page
US Patent:
20030147975, Aug 7, 2003
Filed:
Mar 10, 2003
Appl. No.:
10/385372
Inventors:
Yatindra Joshi - Princeton NJ, US
Russell Somma - Sparta NJ, US
International Classification:
A61K035/78
A61K031/00
US Classification:
424/725100, 424/725000, 424/195180
Abstract:
A pharmaceutical composition which reduces or eliminates the drug abuse potential of central nervous system stimulant comprising: (a) a central nervous system stimulant selected from the group consisting of methylphenidate, amphetamine, methamphetamine, and combinations thereof; and (b) a mucous membrane irritant selected from the group consisting of organic and inorganic acid, salt, ketone, nitrite, sulfide, bisulfate, persulfate, glycerophosphate, hypophosphate, borate, titanate, amino acid, peptide, and combinations thereof, wherein the mucous membrane irritant produces irritation when contacted with the skin or mucous membrane. The present invention is based on the discovery that a central nervous system stimulant, such as methylphenidate, in combination with a mucous membrane irritant, such as citric acid, reduces or eliminates potential drug abuse by producing “irritation” when contacted with the dermis layer of skin or mucous membrane, and thus, prevents nasal absorption and/or injectability of the drug.

Pharmaceutical Composition Which Reduces Or Eliminates Drug Abuse Potential

View page
US Patent:
20040042964, Mar 4, 2004
Filed:
Sep 5, 2003
Appl. No.:
10/656546
Inventors:
Yatindra Joshi - Princeton NJ, US
Russell Somma - Sparta NJ, US
International Classification:
A61K049/00
A61K031/137
US Classification:
424/010100, 514/649000
Abstract:
A pharmaceutical composition which reduces or eliminates the drug abuse potential of central nervous system stimulant comprising: (a) a drug selected from the group consisting of methylphenidate, amphetamine, methamphetamine, and combinations thereof; and (b) a gel forming polymer wherein the gel forming polymer is a polymer that forms a gel when contacted with moisture or placed in an aqueous solution. The present invention is based on the discovery that a central nervous system stimulant, such as methylphenidate in combination with a gel forming polymer reduces or eliminates drug abuse potential by swelling in the presence of moisture, and thus, preventing nasal absorption and injectability of the drug.

Pharmaceutical Composition Which Reduces Or Eliminates Drug Abuse Potential

View page
US Patent:
20070148247, Jun 28, 2007
Filed:
Feb 13, 2007
Appl. No.:
11/705658
Inventors:
Yatindra Joshi - Princeton NJ, US
Russell Somma - Sparta NJ, US
International Classification:
A61K 31/137
A61K 9/14
US Classification:
424486000, 424488000, 514649000
Abstract:
A pharmaceutical composition which reduces or eliminates the drug abuse potential of central nervous system stimulant comprising: (a) a drug selected from the group consisting of methylphenidate, amphetamine, methamphetamine, and combinations thereof; and (b) a gel forming polymer wherein the gel forming polymer is a polymer that forms a gel when contacted with moisture or placed in an aqueous solution. The present invention is based on the discovery that a central nervous system stimulant such as methylphenidate in combination with a gel forming polymer reduces or eliminates drug abuse potential by swelling in the presence of moisture, and thus, preventing nasal absorption and injectability of the drug.

Pharmaceutical Composition Which Reduces Or Eliminates Drug Abuse Potential

View page
US Patent:
20090060848, Mar 5, 2009
Filed:
Nov 3, 2008
Appl. No.:
12/263790
Inventors:
Yatindra Joshi - Princeton NJ, US
Russell Somma - Sparta NJ, US
International Classification:
A61K 31/137
A61K 31/445
US Classification:
424 101
Abstract:
A pharmaceutical composition which reduces or eliminates the drug abuse potential of central nervous system stimulant comprising: (a) a drug selected from the group consisting of methylphenidate, amphetamine, methamphetamine, and combinations thereof; and (b) a gel forming polymer wherein the gel forming polymer is a polymer that forms a gel when contacted with moisture or placed in an aqueous solution. The present invention is based on the discovery that a central nervous system stimulant such as methylphenidate in combination with a gel forming polymer reduces or eliminates drug abuse potential by swelling in the presence of moisture, and thus, preventing nasal absorption and injectability of the drug.
Control profile
Russell F Somma from Sparta, NJ, age ~72 Get Report